海外新药动态与存档
这里汇总欧美日韩等地最近登记或更新、且正在招募患者的新药临床试验，每天自动刷新。 看到合适的，可以点进去查看入组条件和研究团队联系方式，也可以照着写信模板主动联系。出现过的内容都会自动保存到存档里，可随时按中文病名检索。
更新时间：2026/11/1 22:08:33
- 2026-10-30 更新正在招募II 期United States、France、Italy
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
适应症：Multiple Myeloma、Relapsed/Refractory Multiple Myeloma
申办方：C4 Therapeutics, Inc.
- 2026-10-30 更新正在招募II 期 / III 期United States、Belgium、Brazil
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
适应症：Heart Failure、Left Ventricular Systolic Dysfunction
申办方：Merck Sharp & Dohme LLC
- 2026-10-30 更新正在招募不适用United States、Peru
Deciphering the Genetic Architecture of Autoimmune Diseases
适应症：Autoimmune Diseases
申办方：National Human Genome Research Institute (NHGRI)
- 2026-10-30 更新正在招募II 期United States
The COSMYC Trial (COmbined Suppression of MYC)
适应症：Metastatic Castration-resistant Prostate Cancer
申办方：Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2026-10-30 更新正在招募不适用United States
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis
适应症：Nasal Airway Obstruction
申办方：Aerin Medical
- 2026-10-30 更新正在招募不适用Canada
A Study to Assess the Efficacy of a Calcium Sodium Phosphosilicate Toothpaste for the Relief of Dentine Hypersensitivity
适应症：Dentin Sensitivity
申办方：HALEON
- 2026-10-30 更新正在招募I 期United States
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
适应症：Inherited Bone Marrow Failure Syndrome、Familial Platelet Disorder With Predisposition to Myeloid Malignancies
申办方：National Cancer Institute (NCI)
- 2026-10-30 更新正在招募不适用United States
Dietary Intervention for Migraine Relief
适应症：Migraine
申办方：American University
- 2026-10-30 更新正在招募II 期 / III 期Canada、Denmark、France
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
适应症：B-cell Acute Lymphoblastic Leukemia
申办方：Merck Sharp & Dohme LLC
- 2026-10-30 更新正在招募不适用United States、Australia
Comparison of Uncomplicated Candidemia Therapy Duration in Children and Adults
适应症：Invasive Candidiasis
申办方：Arkansas Children's Hospital Research Institute
- 2026-10-30 更新正在招募II 期United States、Australia、France
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
适应症：Immune Thrombocytopenia
申办方：Incyte Corporation
- 2026-10-30 更新正在招募I 期 / II 期United States
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
适应症：Head and Neck Cancer、Head and Neck Squamous Cell Carcinoma、Paranasal Sinus Neoplasms、Nasopharyngeal Carcinoma
申办方：National Cancer Institute (NCI)
- 2026-10-30 更新正在招募I 期United States
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
适应症：Glioblastoma Multiforme、Recurrent Glioblastoma
申办方：Boston Scientific Corporation
- 2026-10-30 更新正在招募I 期United States
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
适应症：Adrenocortical Carcinoma (ACC)、Recurrent Adrenocortical Carcinoma (ACC)、Recurrent Abdominal Adrenocortical Carcinoma (ACC)、Carcinoma, Adrenocortical
申办方：National Cancer Institute (NCI)
- 2026-10-30 更新正在招募II 期 / III 期United States、Australia、Brazil
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
适应症：Primary Membranous Nephropathy
申办方：Vertex Pharmaceuticals Incorporated
招募信息来自 ClinicalTrials.gov，研究进展来自美国国立医学图书馆 PubMed 公开数据；存档记录的是收录当时的信息，试验状态可能已经变化；中文标题为机器翻译，仅供参考，不构成医疗建议。能否参加或用药请与主治医生及研究团队确认。